Video Experimental Relacionado
Updated: Feb 20, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.5K
Cierre Transcatéter de Fuga Paravalvular Mitral y Aórtica: Innovaciones, Desafíos y Direcciones Futuras
Andrea Ruberti1,2,3, Eduardo Flores-Umanzor1,2,3, Laura Sanchis1,2,3
1Department of Cardiology, Cardiovascular Institute, Hospital Clínic, Barcelona, Spain (A. Ruberti, E.F.-U., L.S., A. Regueiro, G.V., O.A.-J.A., P.C.-G., G.O., M.S., B.V., X.F.).
Circulation. Cardiovascular interventions
|February 19, 2026
Resumen
La fuga paravalvular (FPV) es una complicación de las válvulas protésicas. El cierre transcatéter de FPV ofrece una opción de tratamiento eficaz y menos invasiva para fugas significativas en comparación con la reoperación.
Área de la Ciencia:
- Cardiología
- Cardiología Intervencionista
- Cirugía Cardíaca
Sus antecedentes:
- La fuga paravalvular (FPV) es una complicación de las válvulas protésicas, que afecta hasta el 10% de las válvulas aórticas y el 17% de las válvulas mitrales.
- Aunque a menudo son pequeñas, entre el 1 y el 5% de las FPV causan complicaciones significativas como insuficiencia cardíaca y anemia hemolítica.
- La reoperación quirúrgica conlleva altos riesgos, lo que impulsa la búsqueda de tratamientos alternativos.
Objetivo del estudio:
- Revisar la naturaleza compleja de las fugas paravalvulares (FPV).
- Discutir el estudio diagnóstico para FPV.
- Explorar las estrategias de cierre transcatéter de FPV, centrándose en los dispositivos de oclusión para FPV mitral y aórtica.
Principales métodos:
- Revisión de la literatura existente sobre el diagnóstico y tratamiento de la fuga paravalvular (FPV).
- Enfoque en las técnicas y dispositivos de cierre transcatéter.
- Análisis de los resultados del cierre transcatéter de FPV en centros con experiencia.
Principales resultados:
- El cierre transcatéter de FPV es eficaz en centros con experiencia.
- El procedimiento requiere imágenes avanzadas, materiales y técnicas especializadas debido a su complejidad.
- Los dispositivos de oclusión son una estrategia clave para el cierre transcatéter de FPV mitral y aórtica.
Conclusiones:
- El cierre transcatéter de FPV es una alternativa viable y eficaz a la reoperación quirúrgica de alto riesgo.
- Las imágenes avanzadas y las técnicas especializadas son cruciales para el éxito del cierre transcatéter de FPV.
- La investigación adicional y la experiencia del centro son vitales para optimizar las estrategias de tratamiento transcatéter de FPV.
Videos de Conceptos Relacionados
01:26Mitral Stenosis III: Medical Management
328
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
328
01:25Mitral Regurgitation III: Medical Management
403
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
403
01:25Aortic Regurgitation III: Medical Management
479
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
479
01:22Mitral Valve Prolapse II: Assessment and Management
710
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
710
01:19Mitral Valve Prolapse III: Nursing Management
432
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
432
01:27Mitral Valve Prolapse I: Introduction
625
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
625